2m 2m 2m 2m 2m 2m 2m
LENZ THER (LENZ)
NASDAQ
$5.75$0.00 (0.00%)
Price as of Jun 23, 2026 7:14 PM EDT- $182.5MMarket Cap
- -80.91%1-Year Change
- BiotechnologyIndustry
LENZ THER (LENZ)
$5.75$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.6M -89.41% | 15.0M +1,331.30% | 1.0M +200.00% | -1.0M N/A | |
Cost of Revenue | 418,000 N/A | N/A N/A | 0 -100.00% | 10,000 +100.00% | |
Gross Profit | 1.2M -92.20% | 15.0M +1,331.30% | 1.0M +199.05% | -1.1M +21,060.00% | |
Sales and Marketing Expense | 91.1M +216.35% | 28.8M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -18.7M -37.35% | -29.8M -7.27% | -32.1M -55.85% | -72.8M +91.89% | |
Depreciation and Amortization Expense | 287,000 +394.83% | 58,000 -97.59% | 2.4M +2.34% | 2.4M +220.44% | |
Total Operating Expenses | 110.2M +88.07% | 58.6M -56.65% | 135.2M +27.97% | 105.6M +74.77% | |
Operating Profit | -91.1M +55.50% | -58.6M -56.65% | -135.2M +27.97% | -105.6M +74.77% | |
Interest Income | 9.8M +14.07% | 8.6M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 9.8M +14.07% | 8.6M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 9.5M +7.59% | 8.8M -16.11% | 10.5M +129.78% | 4.6M +144.46% | |
Income before Taxes | -81.6M +64.01% | -49.8M -63.19% | -135.2M +27.97% | -105.6M +74.77% | |
Income Taxes | 502,000 +50,100.00% | 1,000 N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -82.1M +65.02% | -49.8M -60.07% | -124.7M +23.35% | -101.1M +42.81% | |
Net Income from Continuing Operations Applicable to Common | -81.6M +64.01% | -49.8M -60.07% | -124.7M +23.35% | -101.1M +42.81% | |
Basic EPS and Net Income | -2.85 +21.79% | -2.34 +6.85% | -2.19 +19.02% | -1.84 -24.90% | |
Diluted EPS and Net Income | -2.85 +21.79% | -2.34 +6.85% | -2.19 +19.02% | -1.84 -24.90% | |
Basic Weighted Average Shares | 28.8M +35.39% | 21.3M -62.67% | 57.0M +3.90% | 54.9M +89.75% | |
Diluted Weighted Average Shares | 28.8M +35.39% | 21.3M -62.67% | 57.0M +3.90% | 54.9M +89.75% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 25.2M +24.91% | 20.2M -89.06% | 184.3M +286.04% | 47.7M -87.34% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 220.5M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 25.2M +24.91% | 20.2M -89.06% | 184.3M -31.31% | 268.2M -28.85% | |
Total Current Assets | 301.4M +42.23% | 211.9M +12.71% | 188.0M -31.72% | 275.4M -27.87% | |
Accumulated Depreciation | 355,000 +422.06% | 68,000 N/A | 0 -100.00% | 3.2M +275.09% | |
Property and Plant and Equipment and Net | 1.2M +82.64% | 651,000 N/A | 0 -100.00% | 22.6M +247.78% | |
Total Long-Term Assets | 2.5M +81.76% | 1.4M N/A | 0 -100.00% | 1.3M +183.92% | |
Total Assets | 305.9M +42.07% | 215.3M +14.25% | 188.5M -41.46% | 321.9M -19.92% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 21.2M +103.60% | 10.4M +116.93% | 4.8M -63.22% | 13.0M +7.41% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 350,000 N/A | 0 N/A | 0 -100.00% | 10.8M +3,323.73% | |
Total Liabilities | 21.5M +91.95% | 11.2M +130.20% | 4.9M -80.97% | 25.6M +42.78% | |
Retained Earnings | -227.1M +56.63% | -145.0M -60.49% | -367.1M +51.42% | -242.4M +71.49% | |
Total Stockholders Equity | 284.3M +39.32% | 204.1M +11.17% | 183.6M -38.04% | 296.3M -22.85% | |
Total Shares Outstanding | 31.3M +13.90% | 27.5M -52.56% | 58.0M -0.004% | 58.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -69.2M +16.47% | -59.4M -34.02% | -90.0M +2.30% | -88.0M +66.46% | |
Capital Expenditures | 827,000 +76.71% | 468,000 -95.69% | 10.9M +64.63% | 6.6M +14.88% | |
Cash from Investing Activities | -75.7M -51.02% | -154.5M -168.25% | 226.3M +193.58% | -241.9M +4,113.64% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 149.7M -24.75% | 199.0M +104,637.89% | 190,000 -68.17% | 597,000 -99.86% | |
Financials Ratio | |||||
Gross Margin | 73.68% N/A | N/A N/A | 100.00% -0.95% | 100.95% N/A | |
Operating Margin | -5,739.17% +1,368.82% | -390.73% -96.97% | -12,899.90% -227.97% | 10,080.06% N/A | |
Return on Assets | -31.52% +27.84% | -24.65% -49.53% | -48.85% +74.96% | -27.92% N/A | |
Return on Equity | -33.63% +30.98% | -25.68% -50.58% | -51.95% +74.88% | -29.71% N/A | |
Revenue Growth | -89.41% -106.72% | 1,331.30% +565.65% | 200.00% N/A | N/A N/A | |
Current Ratio | 14.23 -30.14% | 20.36 -48.04% | 39.20 +85.65% | 21.11 N/A | |
Cash Ratio | 1.19 -38.65% | 1.94 -94.96% | 38.41 +949.66% | 3.66 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow